JonathanEdwardAlpertMDPhD

PubMed

• 185 citations
  Major depressive subtypes and treatment response
  Maurizio Fava, Lisa A. Uebelacker, Jonathan E. Alpert, Andrew A. Nierenberg, Joel A. Pava
  Biological Psychiatry. 1997-10-01
• 29 citations
  Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of anxiety symptoms in major depressive disorder: a meta-analysis of individual ...
  George I. Papakostas, Madhukar H. Trivedi, Jonathan E. Alpert, Cheryl A. Seifert, Alok Krishen
  Journal of Psychiatric Research. 2008-01-01
• 648 citations
  Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.
  Maurizio Fava, A. John Rush, Jonathan E. Alpert, Goundappa K. Balasubramani, Stephen R. Wisniewski
  The American Journal of Psychiatry. 2008-03-01

Journal Articles

• A randomized controlled pilot study on mindfulness-based cognitive therapy for unipolar depression in patients with chronic pain  
  DeJong M, Peeters F, Gard T, Ashih H, Doorley J, Walker R, Rhoades L, Kulich RJ, Kueppenbender KD, Alpert JE, Hoge EA, Britton WB, Lazar SW, Fava M, Mischoulon D, J Clin Psychiatry, 1/28/2017
• A Pilot, Randomized Controlled Study of Tai Chi With Passive and Active Controls in the Treatment of Depressed Chinese Americans  
  Yeung AS, Feng R, Kim DJH, Wayne PM, Yeh GY, Baer L, Lee OE, Denninger JW, Benson H, Fricchione GL, Alpert J, Fava M, J Clin Psychiatry, 1/1/2017
• The Effectiveness of Telepsychiatry-Based Culturally Sensitive Collaborative Treatment for Depressed Chinese American Immigrants: A Randomized Controlled Trial  
  Yeung A, Martinson MA, Baer L, Chen J, Clain A, Williams A, Chang TE, Trinh, NH, Alpert JE, Fava M, J Clin Psych, 1/1/2016
• Clinically relevant complications of drug-food interactions in psychopharmacology  
  Carlo AD, Alpert JE, Psychiatric Annals, 1/1/2016
• Catastrophic Drug-Drug Interactions in Psychopharmacology  
  Carlo AD, Alpert JE, Psychiatric Annals, 1/1/2016
• College students with depressive symptoms with and without fatigue: Differences in functioning, suicidality, anxiety and depressive severity  
  Nyer M, Mischoulon D, Alpert JE, Holt DJ, Bridd CD, Yeung A, Pedrelli P, Baer L, Dording C, Huz I, Fisher L, Fava M, Farabaugh A, Ann Clin Psychiatry, 1/1/2015
• Geriatric psychopharmacology: pharmacodynamic and pharmacokinetic considerations  
  Carlo A, Alpert JE, Psychiatric Annals, 1/1/2015
• Pharmacological approaches to the challenges of treatment-resistant depression  
  Ionescu DF, Rosenbaum JF, Alpert JE, Dialogues Clin Neurosci, 1/1/2015
• Reliability and validity of symptoms of depression questionnaire (SDQ)  
  Pedrelli P, Blais MA, Alpert JE, Shelton RC, Walker RS, Fava M, CNS Spectr, 1/1/2014
• Simulation-based ongoing professional practice evaluation in psychiatry: A novel tool for performance assessment  
  Gorrindo T, Goldfarb E, Birnbaum RJ, Chevalier L, Meller B, Alpert J, Herman J, Weiss A, Jt. Comm. J Qual Patient Saf, 1/1/2013
• Increased Gsalpha within blood cell membrane lipid microdomains in some depressive disorders: an exploratory study  
  Mooney JJ, Samson JA, McHale NL, Pappalarado KM, Alpert JE, Schildkraut JJ, J Psychiatr Res, 1/1/2013
• AMe and sexual functioning  
  Dording CM, Mischoulon D, Shyu I, Alpert JE, Papakostas GI, Eur Psychiatry, 1/1/2012
• Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder and their impact on response to fluoxetine treatment  
  Mischoulon D, Lamon-Fava S, Selhub J, Katz J, Papakostas GI, Iosifescu DV, Yeung AS, Dording CM, Farabaugh AH, Clain AJ, Baer L, Alpert JE, Nierenberg AA, Fava M, CNS Spectr, 1/1/2012
• Effects of s-adenosyl methionine augmentation of serotonin reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder  
  Levkovitz Y, Alpert JE, Brintz CE, Mischoulon D, Papakostas GI, J Affect Disord, 1/1/2012
• Cognitive therapy for anxious depression in STAR*D: What have we learned?  
  Farabaugh A, Alpert J, Wisniewski SR, Otto MW, Fava M, Baer L, Perlis R, Friedman E, Nyer M, Bitran S, Balasubramani GK, Inamori A, Trivedi M, Thase ME, J Affect Disord, 1/1/2012
• Antidepressant effects on emotional temperament toward a biobehavioral research paradigm for major depressive disorder  
  Soskin DP, Carl JR, Alpert J, Fava M, CNS Neuroci Ther, 1/1/2012
• OSCE performance of students with and without a previous core psychiatry clerkship  
  Goisman RM, Levin RM, Krupat E, Pelletier SR, Alpert JE, Acad Psychiatry, 1/1/2010
• Site vs centralized raters in a clinical depression trial: Impact on patient selection and placebo response  
  Kobak KA, Leuchter A, DeBrota D, Englehardt N, Williams JBW, Cook I, Leon AC, Alpert JE, J Clin Psychopharmacol, 1/1/2010
• Cognitive-behavioral therapy for patients with Parkinson's disease and comorbid major depressive disorder  
  Farabaugh A, Locascio JJ, Yap L, Growdon J, Fava M, Crawford C, Matthews J, McCutchen J, Buchin J, Pava J, Alpert JE, Psychosom, 1/1/2010
• An approach to the psychopharmacologic care of patients: antidepressants, antipsychotics, anxiolytics, mood stabilizers and natural remedies  
  Huffman JC, Alpert JE, Med Clin North Am, 1/1/2010
• A double-blind randomized controlled trial of ethyl-eicosapenaenoate (EPA-E) for major depressive disorder  
  Mischoulon D, Papakostas GI, Dording CM, Farabaugh AH, Sonawalla SB, Agoston M, Smith J, Beaumont E, Dahan L, Alpert JE, Nierenberg AA, Fava M, J Clin Psychiatry, 1/1/2009
• Pattern of depressive symptoms in Parkinson's disease  
  Farabaugh AH, Locascio JJ, Yap L, Weintraub D, McDonald WM, Agoston M, Alpert JE, Growdon J, Fava M, Psychosom, 1/1/2009
• Obesity among those with mental disorders: A National Institute of Mental Health Meeting report  
  Allison DV, Newcomer JW, Dunn AL, Blumenthal JA, Fabricatore AN, Daumit GL, Cope MB, Riley WT, Vreeland B, Hibbeln JR, Alpert JE, Am J Prev Med, 1/1/2009
• Adverse endocrine and metabolic effects of psychotropic drugs: selective clinical review  
  Bhuvaneswar CG, Baldessarini RJ, Harsh VL, Alpert JE, CNS Drugs, 1/1/2009
• Factors associate with concomitant psychotropic drug use in the treatment of major depression: A STAR*D report  
  Shelton RC, Hollon SD, Wisniewski SR, Alpert JE, Balasubramani GK, Friedman ES, Rush AJ, Trivedi MH, Preskon SH, CNS Spectr, 1/1/2009
• Join now to see all

Books/Book Chapters

• Massachusetts General Hospital Handbook of General Hospital Psychiatry 
  Chapter: Approaches to Collaborative Care and Behavioral Health Integration. 
  Page 581 - 589Carlo AD, Beck BJ, Weil EM, Alpert JEEditors: Stern TA, Freudenreich O, Smith FA, Fricchione GL, Rosenbaum JF.Elsevier, Philadelphia, PAEdition 7th,2018
• Massachusetts General Hospital Handbook of General Hospital Psychiatry 
  Chapter: Psychopharmacology in the Medical Setting. 
  Page 441 - 466Stevens JR, Fava M, Rosenbaum JF, Alpert JEEditors: Stern TA, Fricchione GL, Cassem NH, Jellinek MS, Rosenbaum JF.Saunders Elsevier, Philadelphia, PAEdition 6th,2010
• Natural Medications for Psychiatric Disorders 
  Chapter: S-Adenosyl-methionine and Folate in the Treatment of Depression. 
  Page 68 - 83Alpert JE, Papakostas GI, Mischoulon DMEditors: Mischoulon DM, Rosenbaum.Lippincott, Williams and Wilkins, Philadelphia2008
• Massachusetts General Hospital Comprehensive Clinical Psychiatry 
  Chapter: Drug-drug interactions in psychopharmacology. 
  Page 687 - 704Alpert JEEditors: Stern TA, Rosenbaum JF, Fava M, Biederman J, Rauch SL.Mosby Elsevier, Philadelphia2008
• Massachusetts General Hospital Handbook of General Hospital Psychiatry 
  Chapter: Psychopharmacological issues in the medical setting. 
  Page 231 - 267Alpert JE, Fava M, Rosenbaum JFEditors: Stern TA, Fricchione GL, Cassem NH, Jellinek MS, Rosenbaum JF.Mosby Inc., Philadelphia, PA2004
• Massachusetts General Hospital Guide to Primary Care Psychiatry 
  Chapter: Drug-drug interactions: the interface between psychotropics and other agents. 
  Page 653 - 669Alpert JEEditors: Stern TA, Herman, JB, Slavin PL.McGraw-Hill, New YorkEdition 2nd,2004
• Drugs for Pain 
  Chapter: Antidepressants: Basic mechanisms and pharmacology. 
  Page 215 - 222Iosifescu DV, Alpert JE, Fava MEditors: Smith HS.Handley and Belfus, Inc., Philadelphia2003
• Massachusetts General Hospital Psychiatry: Update and Board Preparation 
  Chapter: Drug-drug interactions in psychopharmacology. 
  Page 375 - 384Alpert JEEditors: Stern TA, Herman JB.McGraw-Hill, New YorkEdition 2nd,2003
• Handbook of Chronic Depression 
  Chapter: Psychopharmacological approaches to prevention and treatment of relapse and recurrence. 
  Page 231 - 256Petersen TJ, Nierenberg AA, Ryan JL, Alpert JEEditors: Alpert JE, Fava M.Marcel Dekker, Inc., New York2003
• Drugs for Pain 
  Chapter: Antidepressants: clinical management. 
  Page 223 - 239Iosifescu DV, Alpert JE, Fava MEditors: Smith HS.Hanley and Beltus, Inc., Philadelphia2003
• Natural Medications for Psychiatric Disorders: Considering the Alternatives 
  Chapter: One-carbon metabolism and the treatment of depression: roles of S-Adenosyl-Methionine and folic acid. 
  Page 43 - 61Alpert JE, Mischoulon DEditors: Mischoulon D, Rosenbaum JF.Lippincott, Williams and Wilkins, Philadelphia2002
• Treatment Refractory Depression 
  Chapter: Psychiatric comorbidity in treatment-resistant depression. 
  Page 430 - 478Alpert JE, Lagomasino IEditors: Amsterdam J, Hornig M, Nierenberg AA.Cambridge University Press, New York2001
• Massachusetts General Hospital Psychiatry: Update and Board Preparation 
  Chapter: Drug interactions in psychopharmacology. 
  Page 381 - 390Alpert JEEditors: Stern TA, Herman JB.McGraw-Hill, New York2000
• The Massachusetts General Hospital Guide to Psychiatry in Primary Care 
  Chapter: Drug-drug interactions: The interface between psychotropics and other agents. 
  Page 509 - 534Alpert, JEEditors: Stern TA, Herman JB, Slavin PL.McGraw-Hill, New York1998
• Psychiatric Clinics of North America: Anger, Aggression and Violence 
  Chapter: Psychotherapeutic approaches to aggressive and violent patients. 
  Page 453 - 472Alpert, JE, Spillmann MK1997
• Massachusetts General Hospital Handbook of General Hospital Psychiatry 
  Chapter: Psychopharmacological issues in the general medical setting. 
  Page 249 - 303Alpert JE, Bernstein JG, Rosenbaum JFEditors: Cassem EH, Stern TA, Rosenbaum JF, Jellinek MS.Mosby, PhiladelphiaEdition 4th,1997
• Substance P 
  Chapter: Interaction of substance P with dopaminergic neurons in brain. 
  Page 43 - 44Iverson LL, Elliot PJ, Bannon MJ, Alpert JE, Iversen SDEditors: Skranebanek P and Powell D.Boole Press, Dublin1983
• Advances in Neurology: Gilles de la Tourette Syndrome 
  Chapter: Functional organization of the dopamine system in normal and abnormal behavior. 
  Page 69 - 76Iversen SD, Alpert JE1982
• Vulnerabilities to Delinquency 
  Chapter: Behavioral and neurochemical organization disorders of attention, activity, and aggression. 
  Page 109 - 171Alpert JE, Cohen DJ, Shaywitz BA, Piccirillo MEditors: Lewis DO.S.P. Medical and Scientific Books, New York1978
• Join now to see all

Abstracts/Posters

• Subjective sleep quality and suicidal ideation among college students.
  Sonawalla SB, Farabaugh AH, Pender M, Petersen TJ, Yeung A, Alpert JE, Fava M, 160th Annual Meeting of the American Psychiatric Association, San Diego, CA, 1/1/2007
• Management issues in the treatment of depression with comorbid medical disorders.
  Alpert JE, 159th Annual Meeting of the American Psychiatric Association, Toronto, Canada, 1/1/2006
• When does polypharmacy lead to higher remission rates?
  Alpert JE, 159th Annual Meeting of the American Psychiatric Association, Toronto, Canada, 1/1/2006
• Conditional probability to response to placebo in MDD.
  Covino J, Mischoulon D, Alpert JE, Nierenberg AA, Zajecka JM, Murck H, Rosenbaum JF, 159th Annual Meeting of the American Psychiatric Association, Toronto, Canada, 1/1/2006
• Early symptomatic worsening during treatment with fluoxetine in MDD: a replication study.
  Cusin C, Perlis RH, Alpert JE, McGrath PJ, Stewart JW, Quitkin FM, Fava M, 159th Annual Meeting of the American Psychiatric Association, Toronto, Canada, 1/1/2006
• Join now to see all

Lectures

• Psychopharmacology 2012 
  Massachusetts General Hospital Psychiatry Academy, Boston, Massachusetts - 9/28/2012

Other

• Manufacturing depression and the economy of melancholy. 
  Alpert JE, NPR On Point
  1/20/2007
• S-Adenosyl methionine and the treatment of major depression. 
  Alpert JE, Fava M, Practical Reviews Psychiatry, No. 10
  1/1/1999
• Nutrition and depression: the role of folate. 
  Alpert JE; Fava M, Medscape Mental Health
  1/1/1997
• Behavioural Neurobiology of the Dopamine Innervation of Ventral Striatum 
  Alpert JE, University of Cambridge (Ph.D. Theses)
  Cambridge, England - 1/1/1987
• Join now to see all